Mayo Clinic
Drugmakers Come Together Hoping to Formalize MRD as Surrogate Endpoint in AML Trials
MPAACT members will share trial data, aiming to standardize measurable residual disease as a surrogate endpoint for overall survival and speed up drug development. Â
Cancer Genomics Project in Southwestern American Indians Aims to Improve Research, Care Disparities
The NCI-funded project, which was delayed due to the pandemic, is poised to begin, and aims to provide actionable data and build a reference genome for American Indians.
Prostate Cancer Analysis Explores Age-Related Risk Linked to Polygenic Risk Score
While the relative risk associated with a prostate cancer PRS decreased with age, case-control data suggested absolute risk remained fairly stable over time.
Mayo Clinic Exploring PDS Biotech's PDS0101, Merck's Keytruda in HPV-Associated Oropharyngeal Cancer
The investigator-initiated study will evaluate PDS0101 with or without Keytruda prior to surgery in oropharyngeal cancer patients at high risk of recurrence.
Mayo Clinic, Personalis Ink Comprehensive Genomics Research Collaboration
Investigators intend to offer Personalis' comprehensive genomics testing to consenting patients for both clinical use and to aggregate data for ongoing research.